ArticleJournal of personalized medicine2026
Twelve-Month Real-World Outcomes of Tezepelumab in Severe Asthma: Clinical Remission, Biomarker Changes, and Trigger Burden-A SANI Multicenter Cohort.
Stefania Nicola et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.